Thermo Fisher (TMO) announced that it has completed the repurchase of $1B of its common stock. As of December 3, $3B remained available under the company’s share repurchase authorization.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher announces $4B share repurchase program
- Mainz Biomed, Thermo Fisher sign collaboration agreement
- Seer, Thermo Fisher enter co-marketing and sales agreement
- Thermo Fisher price target lowered to $718 from $767 at RBC Capital
- Thermo Fisher price target lowered to $620 from $625 at Bernstein